# K130851: Cascade Hemodialysis/Apheresis Catheter

- Pathway: 510(k) (Traditional)
- Applicant: Health Line International Corporation
- Decided: Jan 9, 2014 after 288 days
- Product code: MSD (Catheter, Hemodialysis, Implanted)
- Device class: 2
- Regulation: 21 CFR 876.5540
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 10 generations back to K001901 (2000). 30 ancestors in all.
1 later device descends from it; 1 cites it directly.
2 of 32 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K113487: Hemo-Cath 10F, Hemo-Cath 12.5F, Medical Components, Inc. (2012) Summary page 2.

## Most influential descendants
- K241581: Hemodialysis Catheter (2025), 0 descendants of its own

## Indications for use
The CASCADE™ Hemodialysis/Apheresis Catheter is indicated for use in attaining Long-Term (greater than 30 days) vascular access for Hemodialysis therapy and Apheresis. It may be inserted percutaneously and is primarily placed in the internal jugular vein of an adult patient. Alternate insertion sites include subclavian vein as required. Catheters greater than 40 cm are intended for femoral vein insertion. The curved CASCADE™ Hemodialysis/Apheresis Catheter is intended for internal jugular vein insertion.

Source page: https://510kreport.com/device/K130851
Methodology: https://510kreport.com/methodology